CLINICAL_TRIALS
trial_result
· 2023-11-29
Clinical Trial Update: Treatment of Pneumocystis in COPD (the TOPIC Study) [Phase 1, Phase 2]
Summary
A Phase 1/2 trial investigating treatment of Pneumocystis in COPD was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Corewell Health East | Conditions: COPD Exacerbation Acute | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-11-29